The Effect of Hydration Status on Glycemic Control and Appetite Regulation
1 other identifier
interventional
16
1 country
1
Brief Summary
The aim of this study is to investigate whether hydration status affects blood sugar control and appetite regulation. In order to do this, participants will undergo a monitoring phase whereby their weight, diet and physical activity are monitored, followed by a dehydration protocol involving fluid restriction and sitting in a heat tent. In one arm of the trial, participants will remain dehydrated for the remainder of the day (i.e. after the heat tent) by having their fluid intake restricted, and in the other arm of the trial, participants will be rehydrated by consuming the necessary amount of plain water. All participants will undergo both arms of the trial, the order of which will be chosen randomly. Several measures will be taken throughout the trial. Before participants go into the heat tent, they will provide a urine sample (for baseline hydration status as indicated by urine osmolality), a blood sample (for glucose, insulin, arginine vasopressin,/copeptin, ghrelin and serum osmolality and plasma volume), and have a peripheral quantitative computer tomography scan of their thigh to indicate muscle size. On the day proceeding the heat tent, participants will have these measures repeated, along with metabolic rate before consuming a 75 g glucose drink, followed by 15 minutely blood samples and hourly metabolic rate measures for 120 minutes (i.e. an oral glucose tolerance test; OGTT). Following this, participants will be presented with a large bowl of pasta and sauce and will be instructed to eat until satisfied (maximum 30 min). Blood samples will be taken every 10 minutes for 60 minutes following the meal. Participants also have the option to opt-in to have a muscle biopsy taken. This will be taken before and \~120 minutes after the glucose drink.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable healthy
Started Jul 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2016
CompletedFirst Submitted
Initial submission to the registry
July 7, 2016
CompletedFirst Posted
Study publicly available on registry
July 22, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2017
CompletedResults Posted
Study results publicly available
June 22, 2020
CompletedJune 22, 2020
June 1, 2020
6 months
July 7, 2016
March 7, 2020
June 18, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Glycemic Response
Primary analysis is time trends (i.e. ANOVA effects), supported by indices of the glycemic response (e.g. iAUC, time to peak). Blood was taken pre-muscle biopsy (if participants opted in for a muscle biopsy), before consuming the glucose drink (after the biopsy, where applicable), then at 15 minutely samples for 120 minutes. After the meal test, blood was drawn at 10 minutely intervals for 60 minutes, starting 30 minutes after commencement of eating.
Measured on day 5 on both trial arms, using the blood sample drawn before the glucose beverage is consumed and the blood samples drawn for the subsequent 120 minutes
Secondary Outcomes (8)
Insulinemic Response
Measured on day 5 on both trial arms, using the blood sample drawn before the glucose beverage is consumed and the blood samples drawn for the subsequent 120 minutes
Arginine Vasopressin and Copeptin Response
Measured on day 5 on both trial arms, using the blood sample drawn before the glucose beverage is consumed and the blood samples drawn for the subsequent 120 minutes (please note: may measure copeptin as a marker of arginine vasopressin)
Ghrelin Response
Measured on day 5 on both trial arms, using the blood sample drawn before the participant starts eating the buffet and the subsequent post-buffet blood samples
Energy Intake
Measured on day 5 on both trial arms from the pasta test meal
Metabolic Rate
Using the metabolic rate data collected on day 5 on both trial arms
- +3 more secondary outcomes
Other Outcomes (5)
Serum Osmolality
Measured from the blood samples on day 4 and day 5 on both trial arms
Plasma Volume
Measured from the blood samples on day 4 and day 5 on both trial arms
Other Metabolites
Collected from the blood samples throughout day 5 of both trial arms
- +2 more other outcomes
Study Arms (2)
Hypohydrated
EXPERIMENTALAfter being dehydrated in the heat tent, participants in this trial arm will be given 3 mL/kg lean body mass to consume over the rest of the day (e.g. a 75 kg participant with a body composition of 85 % fat free mass would consume 191 mL water \[63.75 kg \* 3 mL\])
Rehydrated
EXPERIMENTALAfter being dehydrated in the heat tent, participants in this trial arm will be given 40 mL/kg lean body mass plus 150 % of their water losses (from the heat tent procedure) over the rest of the day (e.g. a 75 kg participant with a body composition of 85 % fat free mass and lost 1 % of their body mass in the heat tent (0.75 kg) would consume 2550 mL \[63.75 kg \* 40 mL\] + 1125 mL \[750 g \* 1.5\], totalling 3675 mL).
Interventions
Eligibility Criteria
You may qualify if:
- Healthy male or female
- Aged 18-60 years
- Able and willing to give informed consent
You may not qualify if:
- Any known metabolic or glucose disorder
- Taking necessary medication (other than contraceptives) or supplements that are known to affect glycaemic control (e.g. chromium, PUFAs)
- Current alcohol or drug dependency
- Aged \< 18 years, or \> 60 years; pregnant or breastfeeding
- Any other factors which are deemed to have the potential to cause harm to the participant and/or could introduce bias into the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Bathlead
- University of Bristolcollaborator
- Loughborough Universitycollaborator
- European Hydration Institutecollaborator
- Economic and Social Research Council, United Kingdomcollaborator
- Lund Universitycollaborator
Study Sites (1)
University of Bath
Bath, Somerset, BA2 7AY, United Kingdom
Related Publications (4)
Taveau C, Chollet C, Waeckel L, Desposito D, Bichet DG, Arthus MF, Magnan C, Philippe E, Paradis V, Foufelle F, Hainault I, Enhorning S, Velho G, Roussel R, Bankir L, Melander O, Bouby N. Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats. Diabetologia. 2015 May;58(5):1081-90. doi: 10.1007/s00125-015-3496-9. Epub 2015 Jan 27.
PMID: 25622862BACKGROUNDRoussel R, Fezeu L, Bouby N, Balkau B, Lantieri O, Alhenc-Gelas F, Marre M, Bankir L; D.E.S.I.R. Study Group. Low water intake and risk for new-onset hyperglycemia. Diabetes Care. 2011 Dec;34(12):2551-4. doi: 10.2337/dc11-0652. Epub 2011 Oct 12.
PMID: 21994426BACKGROUNDKeller U, Szinnai G, Bilz S, Berneis K. Effects of changes in hydration on protein, glucose and lipid metabolism in man: impact on health. Eur J Clin Nutr. 2003 Dec;57 Suppl 2:S69-74. doi: 10.1038/sj.ejcn.1601904.
PMID: 14681716BACKGROUNDZerbe RL, Vinicor F, Robertson GL. Plasma vasopressin in uncontrolled diabetes mellitus. Diabetes. 1979 May;28(5):503-8. doi: 10.2337/diab.28.5.503.
PMID: 108167BACKGROUND
Results Point of Contact
- Title
- Dr Harriet Carroll
- Organization
- University of Bath
Study Officials
- PRINCIPAL INVESTIGATOR
Harriet A Carroll, MRes
University of Bath
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD Student
Study Record Dates
First Submitted
July 7, 2016
First Posted
July 22, 2016
Study Start
July 1, 2016
Primary Completion
January 1, 2017
Study Completion
January 1, 2017
Last Updated
June 22, 2020
Results First Posted
June 22, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, CSR
- Time Frame
- Available (no time restrictions)
- Access Criteria
- Open access; doi URL below for hydration-glycaemia data, related report: https://doi.org/10.1152/japplphysiol.00771.2018; data for hydration-appetite: https://doi.org/10.15125/BATH-00719 and related report: https://doi.org/10.1016/j.physbeh.2019.112725
Anonymised data will be shared